Tag: Lisa Rojkjaer

Nordic Nanovector initiates mid-stage trial of Betalutin in 3L Follicular Lymphoma in US

pharmanewsdaily- October 28, 2018

Nordic Nanovector has opened its first clinical site in the US at Long Beach in California for the PARADIGME trial to evaluate its tumor-seeking anti-CD37 ... Read More